Molecular Cancer
| Discipline | Biology |
|---|---|
| Language | English |
| Edited by | Chi V. Dang |
| Publication details | |
| History | 2002–present |
| Publisher | |
| 41.444 (2021) | |
| Standard abbreviations | |
| ISO 4 | Mol. Cancer |
| Indexing | |
| ISSN | 1476-4598 |
| Links | |
Molecular Cancer is a peer-reviewed open-access scientific journal covering all aspects of cancer research.
The journal is published by BioMed Central and was established in 2002. The editor-in-chief is Chi V. Dang, who is also the scientific director of the Ludwig Institute for Cancer Research.[1]
Molecular Cancer publishes research articles, reviews, and commentaries related to cancer biology, molecular oncology, cancer genetics, epigenetics, signal transduction, and targeted therapy.[2]
Abstracting and indexing[edit]
The journal is indexed in PubMed, and Scopus.[3] The journal has a 2021 impact factor of 41.444, according to the Journal Citation Reports.[4]
References[edit]
- ^ "Ludwig Cancer Research". Retrieved 2023-02-19.
- ^ "Molecular Cancer". BioMed Central. Retrieved 2023-02-19.
- ^ "Source details: Molecular Cancer". Scopus Preview. Elsevier. Retrieved 2023-02-12.
- ^ "Molecular Cancer". 2021 Journal Citation Reports. Web of Science (Science ed.). Clarivate. 2022.
External links[edit]
  | This article about an oncology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |